Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure (NORFLOCIR)

This study has been terminated.
(lack of recruitement)
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris Identifier:
First received: December 21, 2009
Last updated: December 8, 2015
Last verified: November 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2015
  Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)